CCDR: Vol. 46 No. 4-April 2020: Respiratory syncytial virus (RSV)


Table of contents

Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada
A Killikelly, M Tunis, A House, C Quach, W Vaudry, D Moore

Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat
A Killikelly, A Shane, MW Yeung, M Tunis, C Bancej, A House, W Vaudry, D Moore, C Quach

Summary of RSV vaccine product in late-stage development

Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018
Y Wei, K Wilkinson, R Rusk, K Kadkhoda, C Loeppky

Measles surveillance in Canada: 2018
C Coulby, F Reyes Domingo, J Hiebert, D MacDonald

Epidemiology study
Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016
T Hirama, N Sabur, P Derkach, J McNamee, H Song, T Marras, S Brode

Motivational interviewing: A powerful tool to address vaccine hesitancy
A Gagneur

Coronavirus disease (COVID-19): For health professionals

Search CCDR

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: